BioRestorative Therapies (OTCMKTS:BRTX) Shares Cross Below 50 Day Moving Average – Should You Sell?

BioRestorative Therapies, Inc. (OTCMKTS:BRTXGet Free Report)’s stock price crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $1.66 and traded as low as $1.57. BioRestorative Therapies shares last traded at $1.60, with a volume of 23,347 shares traded.

BioRestorative Therapies Price Performance

The stock has a market capitalization of $10.97 million, a P/E ratio of -0.70 and a beta of 63.02. The stock’s fifty day moving average is $1.66 and its 200-day moving average is $1.57.

BioRestorative Therapies (OTCMKTS:BRTXGet Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.50) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.56) by $0.06. BioRestorative Therapies had a negative net margin of 13,728.83% and a negative return on equity of 120.47%. The firm had revenue of $0.09 million during the quarter, compared to analysts’ expectations of $0.03 million. On average, research analysts expect that BioRestorative Therapies, Inc. will post -3.52 EPS for the current year.

About BioRestorative Therapies

(Get Free Report)

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.

Featured Articles

Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.